<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55005166"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
			<lb/>
			<reference>Thrombosis Research 102 (2001) 61 ± 69<lb/></reference>
			<note type="articleType">REGULAR ARTICLE<lb/></note>
			<docTitle>
				<titlePart>Matrix Metalloproteinase Deficiencies Do Not
					Impair<lb/> Cell-Associated Fibrinolytic Activity<lb/></titlePart>
			</docTitle>

			<byline>
				<docAuthor>Francisca Ugwu, Gudule Lemmens, Desire Collen and H. Roger Lijnen<lb/></docAuthor>
			</byline>

			<byline>
				<affiliation>Center for Molecular and Vascular Biology, University of
					Leuven,</affiliation>
			</byline>

			<address>Campus Gasthuisberg, O&amp;N, Herestraat 49,<lb/> B-3000 Leuven, Belgium<lb/></address>

			<note type="submission">(Received 12 October 2000 by Editor J. Soria; revised/accepted 20 December 2000)<lb/></note>

<div type="abstract">
	Abstract<lb/>
	The matrix metalloproteinase (MMP) and fibri-<lb/>
	nolytic (plasminogen/plasmin) systems coop-<lb/>
	erate in many (patho)physiological processes<lb/>
	requiring extracellular proteolysis. The effect of<lb/>
	MMP-3 (stromelysin-1), MMP-7 (matrilysin),<lb/>
	MMP-9 (gelatinase B) or MMP-12 (metalloelas-<lb/>
	tase) on cellular fibrinolytic activity was studied<lb/>
	with the use of smooth muscle cells (SMC) and<lb/>
	fibroblasts derived from mice with specific<lb/>
	inactivation of these genes. Activation of cell-<lb/>
	bound plasminogen by two-chain urokinase-type<lb/>
	plasminogen activator (tcu-PA) was not signifi-<lb/>
	cantly different with SMC or fibroblasts from the<lb/>
	gene-deficient mice (78% to 140% of wild-type).<lb/>
	For all cell types, very limited conversion of<lb/>
	plasminogen to angiostatin-like kringle-contain-<lb/>
</div>

			<keywords>
				Abbreviations: e-ACA, e-aminocaproic acid; MMP-3, MMP-3<lb/>
				(stromelysin-1)-deficient; MMP-7À/À, MMP-7 (matrilysin)-defi-<lb/>
				cient; MMP-9À/À, MMP-9 (gelatinase B)-deficient; MMP-12À/À,<lb/>
				MMP-12 (metalloelastase)-deficient; SMC, smooth muscle cells;<lb/>
				LBS, plasminogen fragment containing kringles 1 to 3 or 1 to 4<lb/>
				with the lysine-binding sites; MAb, monoclonal antibody; S-<lb/>
				2403, D-Glp-Phe-Lys-p-nitroanilide; tcu-PA, two-chain uroki-<lb/>
				nase-type plasminogen activator; WT, wild-type.<lb/>
			</keywords>
			
<note type="other">Corresponding author: Dr. Henri Roger Lijnen, Center for
Molecular and Vascular Biology, University of Leuven, Campus
Gasthuisberg, O&amp;N, Herestraat 49, B-3000 Leuven, Belgium.
Tel: +32 (16) 345775; Fax: +32 (16) 345990; E-mail: &lt;roger.lijnen
@med.kuleuven.ac.be&gt;.</note>

<div type="abstract">
			ing fragments was observed ( &lt; 3% of the total<lb/>
	cell-bound plasminogen). Activation of plasmi-<lb/>
	nogen in solution by cell-associated tcu-PA was<lb/>
	also comparable for SMC or fibroblasts of the<lb/>
	different genotypes (54% to 160% of wild-type).<lb/>
	In vitro SMC migration on scrape wounded<lb/>
	collagen-coated surfaces was comparable for<lb/>
	wild-type, MMP-7 À / À , MMP-9 À / À and MMP-<lb/>
	12 À / À SMC, but was significantly reduced for<lb/>
			MMP-3 À / À SMC ( P &lt; .005 vs. wild-type). Ser-<lb/>
	um-free conditioned medium of MMP-3 À / À and<lb/>
	MMP-7 À / À SMC or fibroblasts induced similar<lb/>
	lysis of fibrin films as wild-type cells. These<lb/>
	findings indicate that several interactions that<lb/>
	have been described between these MMPs and<lb/>
	the plasminogen/plasmin system in a purified<lb/>
	system do not significantly affect plasmin-<lb/>
	mediated cellular fibrinolytic activity under cell<lb/>
	culture conditions.<lb/>
	</div>
	
	<note type="copyright">  2001 Elsevier Science Ltd.
	All rights reserved.</note>
	
	<keywords>Key Words: Fibrinolysis; Matrix metalloproteinases; Plas-<lb/>
		min(ogen); Smooth muscle cells; Fibroblasts; Gene-<lb/>
		deficient mice<lb/></keywords>
	

		</front>
	</text>
</tei>
